Cargando…

A miR-9-5p/FOXO1/CPEB3 Feed-Forward Loop Drives the Progression of Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death worldwide, but its regulatory mechanism remains unclear and potential clinical biomarkers are still lacking. Co-regulation of TFs and miRNAs in HCC and FFL module studies may help to identify more precise and critical...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Hui, Huang, Wei, Zhang, Hong, Li, Jianye, Zhang, Qiong, Miao, Ya-Ru, Hu, Fei-Fei, Gan, Lu, Su, Zhenhong, Yang, Xiangliang, Guo, An-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265408/
https://www.ncbi.nlm.nih.gov/pubmed/35805200
http://dx.doi.org/10.3390/cells11132116
_version_ 1784743206600048640
author Hu, Hui
Huang, Wei
Zhang, Hong
Li, Jianye
Zhang, Qiong
Miao, Ya-Ru
Hu, Fei-Fei
Gan, Lu
Su, Zhenhong
Yang, Xiangliang
Guo, An-Yuan
author_facet Hu, Hui
Huang, Wei
Zhang, Hong
Li, Jianye
Zhang, Qiong
Miao, Ya-Ru
Hu, Fei-Fei
Gan, Lu
Su, Zhenhong
Yang, Xiangliang
Guo, An-Yuan
author_sort Hu, Hui
collection PubMed
description Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death worldwide, but its regulatory mechanism remains unclear and potential clinical biomarkers are still lacking. Co-regulation of TFs and miRNAs in HCC and FFL module studies may help to identify more precise and critical driver modules in HCC development. Here, we performed a comprehensive gene expression and regulation analysis for HCC in vitro and in vivo. Transcription factor and miRNA co-regulatory networks for differentially expressed genes between tumors and adjacent tissues revealed the critical feed-forward loop (FFL) regulatory module miR-9-5p/FOXO1/CPEB3 in HCC. Gain- and loss-of-function studies demonstrated that miR-9-5p promotes HCC tumor proliferation, while FOXO1 and CPEB3 inhibit hepatocarcinoma growth. Furthermore, by luciferase reporter assay and ChIP-Seq data, CPEB3 was for the first time identified as a direct downstream target of FOXO1, negatively regulated by miR-9-5p. The miR-9-5p/FOXO1/CPEB3 FFL was associated with poor prognosis, and promoted cell growth and tumor progression of HCC in vitro and in vivo. Our study identified for the first time the existence of miR-9-5p/FOXO1/CPEB3 FFL and revealed its regulatory role in HCC progression, which may represent a new potential target for cancer therapy.
format Online
Article
Text
id pubmed-9265408
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-92654082022-07-09 A miR-9-5p/FOXO1/CPEB3 Feed-Forward Loop Drives the Progression of Hepatocellular Carcinoma Hu, Hui Huang, Wei Zhang, Hong Li, Jianye Zhang, Qiong Miao, Ya-Ru Hu, Fei-Fei Gan, Lu Su, Zhenhong Yang, Xiangliang Guo, An-Yuan Cells Article Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death worldwide, but its regulatory mechanism remains unclear and potential clinical biomarkers are still lacking. Co-regulation of TFs and miRNAs in HCC and FFL module studies may help to identify more precise and critical driver modules in HCC development. Here, we performed a comprehensive gene expression and regulation analysis for HCC in vitro and in vivo. Transcription factor and miRNA co-regulatory networks for differentially expressed genes between tumors and adjacent tissues revealed the critical feed-forward loop (FFL) regulatory module miR-9-5p/FOXO1/CPEB3 in HCC. Gain- and loss-of-function studies demonstrated that miR-9-5p promotes HCC tumor proliferation, while FOXO1 and CPEB3 inhibit hepatocarcinoma growth. Furthermore, by luciferase reporter assay and ChIP-Seq data, CPEB3 was for the first time identified as a direct downstream target of FOXO1, negatively regulated by miR-9-5p. The miR-9-5p/FOXO1/CPEB3 FFL was associated with poor prognosis, and promoted cell growth and tumor progression of HCC in vitro and in vivo. Our study identified for the first time the existence of miR-9-5p/FOXO1/CPEB3 FFL and revealed its regulatory role in HCC progression, which may represent a new potential target for cancer therapy. MDPI 2022-07-05 /pmc/articles/PMC9265408/ /pubmed/35805200 http://dx.doi.org/10.3390/cells11132116 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Hu, Hui
Huang, Wei
Zhang, Hong
Li, Jianye
Zhang, Qiong
Miao, Ya-Ru
Hu, Fei-Fei
Gan, Lu
Su, Zhenhong
Yang, Xiangliang
Guo, An-Yuan
A miR-9-5p/FOXO1/CPEB3 Feed-Forward Loop Drives the Progression of Hepatocellular Carcinoma
title A miR-9-5p/FOXO1/CPEB3 Feed-Forward Loop Drives the Progression of Hepatocellular Carcinoma
title_full A miR-9-5p/FOXO1/CPEB3 Feed-Forward Loop Drives the Progression of Hepatocellular Carcinoma
title_fullStr A miR-9-5p/FOXO1/CPEB3 Feed-Forward Loop Drives the Progression of Hepatocellular Carcinoma
title_full_unstemmed A miR-9-5p/FOXO1/CPEB3 Feed-Forward Loop Drives the Progression of Hepatocellular Carcinoma
title_short A miR-9-5p/FOXO1/CPEB3 Feed-Forward Loop Drives the Progression of Hepatocellular Carcinoma
title_sort mir-9-5p/foxo1/cpeb3 feed-forward loop drives the progression of hepatocellular carcinoma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265408/
https://www.ncbi.nlm.nih.gov/pubmed/35805200
http://dx.doi.org/10.3390/cells11132116
work_keys_str_mv AT huhui amir95pfoxo1cpeb3feedforwardloopdrivestheprogressionofhepatocellularcarcinoma
AT huangwei amir95pfoxo1cpeb3feedforwardloopdrivestheprogressionofhepatocellularcarcinoma
AT zhanghong amir95pfoxo1cpeb3feedforwardloopdrivestheprogressionofhepatocellularcarcinoma
AT lijianye amir95pfoxo1cpeb3feedforwardloopdrivestheprogressionofhepatocellularcarcinoma
AT zhangqiong amir95pfoxo1cpeb3feedforwardloopdrivestheprogressionofhepatocellularcarcinoma
AT miaoyaru amir95pfoxo1cpeb3feedforwardloopdrivestheprogressionofhepatocellularcarcinoma
AT hufeifei amir95pfoxo1cpeb3feedforwardloopdrivestheprogressionofhepatocellularcarcinoma
AT ganlu amir95pfoxo1cpeb3feedforwardloopdrivestheprogressionofhepatocellularcarcinoma
AT suzhenhong amir95pfoxo1cpeb3feedforwardloopdrivestheprogressionofhepatocellularcarcinoma
AT yangxiangliang amir95pfoxo1cpeb3feedforwardloopdrivestheprogressionofhepatocellularcarcinoma
AT guoanyuan amir95pfoxo1cpeb3feedforwardloopdrivestheprogressionofhepatocellularcarcinoma
AT huhui mir95pfoxo1cpeb3feedforwardloopdrivestheprogressionofhepatocellularcarcinoma
AT huangwei mir95pfoxo1cpeb3feedforwardloopdrivestheprogressionofhepatocellularcarcinoma
AT zhanghong mir95pfoxo1cpeb3feedforwardloopdrivestheprogressionofhepatocellularcarcinoma
AT lijianye mir95pfoxo1cpeb3feedforwardloopdrivestheprogressionofhepatocellularcarcinoma
AT zhangqiong mir95pfoxo1cpeb3feedforwardloopdrivestheprogressionofhepatocellularcarcinoma
AT miaoyaru mir95pfoxo1cpeb3feedforwardloopdrivestheprogressionofhepatocellularcarcinoma
AT hufeifei mir95pfoxo1cpeb3feedforwardloopdrivestheprogressionofhepatocellularcarcinoma
AT ganlu mir95pfoxo1cpeb3feedforwardloopdrivestheprogressionofhepatocellularcarcinoma
AT suzhenhong mir95pfoxo1cpeb3feedforwardloopdrivestheprogressionofhepatocellularcarcinoma
AT yangxiangliang mir95pfoxo1cpeb3feedforwardloopdrivestheprogressionofhepatocellularcarcinoma
AT guoanyuan mir95pfoxo1cpeb3feedforwardloopdrivestheprogressionofhepatocellularcarcinoma